搜索结果21-30 的 27155 / Maximum

  1. 血液科- 临床试验- 妙佑医疗国际

    The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD and ...

  2. 血液科- 临床试验- 妙佑医疗国际

    The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD and ...

  3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... maximum dose that can be administered until adverse effects prevent further dose increases (i.e., the MTD or recommended phase 2 dose), and the dose ...

  4. CAR-T 细胞疗法计划- 临床试验- 妙佑医疗国际

    ... maximum tolerated dose (MTD). A Study to Provide Access to CTL019 Out of Specification Managed Access Program (MAP) for ALL or DLBCL Patients. Jacksonville ...

  5. 血液科- 临床试验- 妙佑医疗国际

    The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD and ...

  6. 肺科- 临床试验- 妙佑医疗国际

    ... maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D), as well as to evaluate preliminary effectiveness. A Biorepository to Study Portopulmonary ...

  7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... maximum dose that can be administered until adverse effects prevent further dose increases (i.e., the MTD or recommended phase 2 dose), and the dose ...

  8. 肺科- 临床试验- 妙佑医疗国际

    The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...

  9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of this study is to determine the maximum tolerated dose, and evaluate its safety, tolerability, preliminary clinical effects, and drug/body ...

  10. 血液科- 临床试验- 妙佑医疗国际

    The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD and ...